Article Information
History
- August 9, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Lao-Tzu Allan-Blitz, MD1,*,
- Kevin Carragher, MD2,
- Adam Sukhija-Cohen3,
- Hong Li, MD4 and
- Jeffrey D. Klausner, MD, MPH2,†
- 1Brigham and Women’s Hospital, Boston, MA
- 2Keck School of Medicine, University of Southern California, Los Angeles, CA
- 3AIDS Healthcare Foundation, Los Angeles, CA
- 4Flow Health, Los Angeles, CA
- ↵*Corresponding Author Contact Information:
Lao-Tzu Allan-Blitz, Department of Medicine, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA, Email: lallan-blitz{at}partners.org, phone: (805) 896-5313 - ↵†Alternative Author Information
: Dr. Jeffrey D. Klausner, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA, Email: jdklausner{at}med.usc.edu
Posted August 09, 2022.
Laboratory Validation and Clinical Implementation of Human Monkeypox Saliva-Based Tests
